When Pfizer came to set up its Twitter account in 2009, the social network was already a big deal, with users sending 100,000 tweets per hour when Michael Jackson died. Arriving late to the party meant the @Pfizer handle was already taken. Now, four years later, Pfizer has finally claimed the account.
Life science vendors face a balancing act when using social media. Giving users the hard sell will bring rejection and reflect badly on the company, but a softly-softly plan might not be noticed at all. Fortunately for vendors, a survey suggests scientists are increasingly accepting of companies on Facebook and Twitter.
Treato CEO Ido Hadari has been trying to convince pharma companies that his startup's software offers advances from so-called "social media listening" applications.
For all their speedy sequencing of genomes, scientists have yet to figure out what all the DNA data mean about diseases, holding back the information from being used in patient treatment.
Denver-based market research startup GutCheck has found $4 million for a Series B round of financing.
Slow-moving regulators have kept the rules of engagement on social media platforms fuzzy for pharma players. Yet rather than sit on the sidelines waiting for the FDA to take a firm stance on dos and don'ts, many pharma companies have taken a shot at safe moves in the social realm. Potentially powerful collaboration tools have also attracted pharma groups, bringing scientists, patients and physicians into the same digital arenas to share ideas and partner on research. Read the report >>
Bill Gates has added his high-profile name and dollars to the open-science movement.
IMS Health has made its third cloud-based acquisition in as many months, snapping up mobile sales and marketing systems provider 360 Vantage. The deal continues IMS' whirlwind push into the cloud that has also seen it snag Appature and Semantelli in the past few months.
Merck's U.K. group has raised its level of play in an industry-wide competition for the attention of physicians as they use the Internet.
A survey of so-called health activists by Extrovertic and WEGO Health found that many patients with multiple sclerosis have an "insatiable appetite" for updated information